Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum levels of RIPK3 and troponin I as potential biomarkers for predicting impaired left ventricular function in patients with myocardial infarction with ST segment elevation and normal troponin I levels prior percutaneous coronary intervention.
Kashlov JK, Donev IS, Doneva JG, Valkov VD, Kirkorova AD, Ghenev PI, Conev NV, Radeva TR, Ivanov BD, Georgieva ZT. Kashlov JK, et al. Biosci Trends. 2016 Sep 5;10(4):294-9. doi: 10.5582/bst.2016.01077. Epub 2016 Jul 18. Biosci Trends. 2016. PMID: 27431004 Free article.
Role of the pretreatment 18F-fluorodeoxyglucose positron emission tomography maximal standardized uptake value in predicting outcomes of colon liver metastases and that value's association with Beclin-1 expression.
Dimitrova EG, Chaushev BG, Conev NV, Kashlov JK, Zlatarov AK, Petrov DP, Popov HB, Stefanova NT, Klisarova AD, Bratoeva KZ, Donev IS. Dimitrova EG, et al. Biosci Trends. 2017 May 23;11(2):221-228. doi: 10.5582/bst.2016.01205. Epub 2017 Feb 28. Biosci Trends. 2017. PMID: 28250335 Free article.
Rare case of ameloblastoma with pulmonary metastases.
Valkadinov I, Conev N, Dzhenkov D, Donev I. Valkadinov I, et al. Among authors: conev n. Intractable Rare Dis Res. 2017 Aug;6(3):211-214. doi: 10.5582/irdr.2017.01032. Intractable Rare Dis Res. 2017. PMID: 28944145 Free PMC article.
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer.
Petrova MP, Eneva MI, Arabadjiev JI, Conev NV, Dimitrova EG, Koynov KD, Karanikolova TS, Valev SS, Gencheva RB, Zhbantov GA, Ivanova AI, Sarbianova II, Timcheva CV, Donev IS. Petrova MP, et al. Biosci Trends. 2020 Mar 16;14(1):48-55. doi: 10.5582/bst.2019.01279. Epub 2020 Feb 4. Biosci Trends. 2020. PMID: 32023563 Free article.
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer.
Petrova MP, Donev IS, Radanova MA, Eneva MI, Dimitrova EG, Valchev GN, Minchev VT, Taushanova MS, Boneva MV, Karanikolova TS, Gencheva RB, Zhbantov GA, Ivanova AI, Timcheva CV, P Pavlov B, Megdanova VG, Robev BS, Conev NV. Petrova MP, et al. Among authors: conev nv. Clin Exp Immunol. 2020 Dec;202(3):353-362. doi: 10.1111/cei.13505. Epub 2020 Aug 26. Clin Exp Immunol. 2020. PMID: 32757277 Free PMC article.
26 results